ADx NeuroSciences

Technologiepark 94
9000 Zwijnaarde
BE
ADx NeuroSciences
Foundation date
16/09/2011
Sector
#Biotechnology - TherapeuticsSubsector
We create tailor-made antibodies and assays to quantify unique biomarkers in a wide variety of neurodegenerative diseases and conditions such as Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. Our assays enable early detection before symptoms appear, providing valuable information from the drug development phase up to clinical practice, to improve the life of patients.
Upcoming events
All events-
0310 '23
-
1810 '23
EMDS2023@VIB
Event by: VIB -
1212 '23
BioFIT 2023
Event by: Eurasanté
Latest news
More news-
argenx announces VYVGART (efgartigimod alfa) authorized for sale by Health Canada for generalized myasthenia gravis
Thursday September 21st 2023
Read more
-
Galapagos appoints Simon Sturge to its Board of Directors
Tuesday September 19th 2023
Read more
-
13th Investment for HERAN Partners: Broken String Biosciences (UK)
Tuesday September 19th 2023
Read more
Jobs
More jobs-
-
-
23/09/23
East Flanders
ERC-funded postdoc position on inter-organelle communication during plant biotic stress responses
Permanent
VIB